In this week’s platter we consider whether remote patient monitoring technologies translate into improved patient health; we look at the 3 industry tycoons who want to fix health care in the US; we study the application of artificial intelligence in big pharma; we look at Apple’s lesson for healthcare innovation; and finally, we get introduced to DNA portraits. Enjoy!
Enthusiasm for remote patient monitoring (RPM) is growing, and it’s no wonder. The latest wave in health data collection uses non-invasive devices (think smart watches, smart phones, and other wearables) to automatically transmit data to a web portal or mobile app for patient self-monitoring and/or health provider assessment and clinical decision-making. Could the use of these exciting technologies actually translate into improved patient health? Researchers found that RPM could be impactful—so long as it was coupled with interventions that integrated new experiences, such as personalized health coaching, into the care model. While that’s good news, we should ask ourselves: why wasn’t the technology alone enough to move the needle?
On Monday, Jeff Bezos, Warren Buffett and Jamie Dimon announced that their three companies -Amazon, Berkshire Hathaway and JPMorgan Chase- would create a new company to develop a better health care solution for their U.S. employees. Given the resources of the companies, and their history of concentrating on the long-term rather than just the near-term, they have a chance to make significant changes in the way health care is provided. Still, it won’t be an easy industry to change.
As India marches ahead, the nation still struggles with substantial issues and worrying gaps in it’s healthcare system. An imminent solution which can have an immediate impact on improving India’s health status, without the additional economic burden of increased expenditure on healthcare infrastructure, is home healthcare. Increasing penetration of internet and technological improvements in healthcare will act as strong enablers in delivery of services at a patient’s home. This article posits that it is time for India to proactively consider home healthcare as a solution for the multiple challenges faced by it’s healthcare industry.
Precision medicine allows accurate disease prevention and treatment tailored to an individual by combining knowledge of a person’s environment, their genetic make-up and protein levels.
The world’s leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines. The aim is to harness modern supercomputers and machine learning systems to predict how molecules will behave and how likely they are to make a useful drug, thereby saving time and money on unnecessary tests. In fact, experts believe that AI systems could deliver drug candidates in roughly one-quarter of the time and at one-quarter of the cost of traditional approaches. Let’s hope that this contributes to a net reduction of health-care costs
In this video, Rebecca Fogg explains what the iPhone can teach us about Disruptive Innovation in healthcare to audiences at the Imperial College London Business School’s 2017 innovation conference
You can get your own DNA portrait!!! In the era of personalized genetics, it’s a perfect example of how industry will use these methods to explore all the financial possibilities. DNA Portraits are the world’s most unique and personalized form of art. No two prints will ever be alike (but for those who cannot read DNA, the portrait remains beautiful, even if it is not unique).